[276] |
Zhang et.al 2020 |
Research in vitro |
If RSV with or without SrRn has differentiating power on the MSC;
If RSV with or without SrRn inhibits the action of osteoclasts;
If RSV with or without SrRn induces angiogenesis
If in rats rehabilitated with 3D scaffolds with RSV associated or not with SrRn, there is bone formation
|
|
MSC proliferation in scaffolds with SrRn is greater than other groups;
Action of osteoclasts is inhibited in scaffolds with RSV, SrRn and both;
Angiogenic effect is greatest in scaffolds with RSV;
High bone formation in mandible with scaffolds with RVS and SrRn compared to the other two groups.
|
[95] |
Borsani et.al 2018 |
Research in vitro |
The researchers wanted to see how CGFs and/or resveratrol affected the proliferation and differentiation of human osteoblasts, whether they were treated with bisphosphonates or not. |
Osteoblast growth medium (OGM): control group OGM + RSV 10 µM OGM + AL 5 µM OGM + ZOL 5 µM OGM + AL 5 µM +RSV 10 µM OGM + ZOL 5 µM +RSV 10 µM OGM + CGF OGM + CGF + RSV 10 µM OGM + CGF + AL 5 µM OGM + CGF + ZOL 5 µM OGM + CGF + RSV 10 µM + AL 5 µM OGM + CGF + RSV 10 µM + ZOL 5 µM |
CGF and RSV both have an osteogenic impact and protect ZOL-treated osteoblasts;
In osteoblasts treated with RSV + ZOL or CGF + RSV + ZOL, OPG levels are higher;
BMP-2 levels rose sharply in osteoblasts treated with CGF + RSV + AL or CGF + RSV + ZOL, but not as much as in osteoblasts treated with CGF + ZOL;
There is a rise in SIRT-1 and Col 1 in osteoblastic cells treated with RSV + CGF + ZOL;
Human osteoblastic cells treated with RSV deposited substantial amounts of calcium.
|